Neoadjuvant hormonal therapy in prostate cancer - impact of PSA level before radiotherapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10195143" target="_blank" >RIV/00216208:11110/13:10195143 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15110/13:33147994 RIV/00179906:_____/13:10195143 RIV/00216275:25520/14:39898917
Result on the web
<a href="http://www.jbuon.com/pdfs/949-953.pdf" target="_blank" >http://www.jbuon.com/pdfs/949-953.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Neoadjuvant hormonal therapy in prostate cancer - impact of PSA level before radiotherapy
Original language description
To retrospectively investigate the impact of prostate specific antigen (PSA) level after neoadjuvant androgen-deprivation therapy (ADT) on biochemical relapse-free survival in patients with prostate cancer who received radical radiotherapy (RT).
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of B.U.ON.
ISSN
1107-0625
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
4
Country of publishing house
GR - GREECE
Number of pages
5
Pages from-to
949-953
UT code for WoS article
000331593700021
EID of the result in the Scopus database
—